Myriad Genetics (MYGN) NewsBite - MYGN Upgraded By Morgan Joseph & Co. Inc.

Posted: Wednesday, November 11, 2009 12:27 PM EDT

Myriad Genetics (MYGN) was upgraded today by analysts at Morgan Joseph & Co. Inc. and the stock is now at $23.70, down $0.16 (-0.65%) on volume of 1,405,598 shares traded. Morgan Joseph & Co. Inc. upgraded the stock today to Hold from Sell. Over the last 52 weeks the stock has ranged from a low of $22.38 this month to a high of $47.08 in March. Myriad Genetics stock has been showing support around $22.68 and resistance in the $24.50 range. Technical indicators for the stock are and S&P does not currently have a STARS rating for MYGN. If you are looking for a hedged play on MYGN the stock seems like it could be a candidate for a January out-of-the-money bull-put credit spread below the 20 range. [ABR-Seven Summits Strategic Investments NewsBite]

Click Symbol For More News On: (MYGN)